Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine

European Journal of Pharmaceutical Sciences

Volumn 44, Issue 1-2, 2011, Pages 127-135

  Wang, Ting ^a   Wang, Ning ^a   Song, Hui ^a   Xi, Xiaonan ^a   Wang, Jianan ^a   Hao, Aijun ^b   Li, Tiefu ^c  

^a JINING MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Emulsion; Hypoglycemic effect; Lyophilization; Oily formulation; Pharmacokinetics; Phosphatidylcholine

Indexed keywords

BERBERINE; PHOSPHATIDYLCHOLINE; WATER OIL CREAM;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; FREEZE DRYING; GLUCOSE BLOOD LEVEL; PRIORITY JOURNAL; REVERSE MICELLE; STREPTOZOCIN DIABETES;

ADMINISTRATION, ORAL; ANIMALS; BERBERINE; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CRYSTALLIZATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; HYPOGLYCEMIC AGENTS; LIGHT; MALE; MICE; MICE, INBRED STRAINS; MICELLES; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR STRUCTURE; MOUTH MUCOSA; NANOPARTICLES; PARTICLE SIZE; SCATTERING, RADIATION; SOLUBILITY; STREPTOZOCIN; SURFACE PROPERTIES;

EID: 80052022736     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.06.015     Document Type: Conference Paper

References (37)

1. I.M. Al-masri, M.K. Mohammad, and M.O. Tahaa Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine J. Enzyme Inhib. Med. Chem. 24 2009 1061 1066
2. S. Chen, and Y. Lin Quintessence of Material Medica first ed. 2006 Chinese Military Medical Science Publishing House Beijing
3. C.L. Chen, S.F. Chang, D. Lee, L.Y. Yang, Y.H. Lee, C.Y. Hsu, S.J. Lin, and J. Liaw Bioavailability effect of methylprednisolone by polymeric micelles Pharm. Res. 25 2008 39 47
4. A.F. Cicero, and S. Ertek Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results Clin. Lipidol. 4 2009 553 563
5. J.D. Clark, R.L. Baldwin, K.A. Bayne, M.J. Brown, G.F. Gebhart, J.C. Gonder, J.K. Gwathmey, M.E. Keeling, D.F. Kohn, J.W. Robb, O.A. Smith, J.A.D. Steggerda, J.G. Vandenbergh, W.J. White, S. Williams-Blangero, and J.L. VandeBerg Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, DC
6. Cok, A., Plaisier, C., Salie, M.J., Oram, D.S., Chenge, J., Louters, L.L., in press. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie. doi:10.1016/j.biochi.2011.04.013.
7. D.Q. Craig, P.G. Royall, V.L. Kett, and M.L. Hopton The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems Int. J. Pharm. 179 1999 179 207 (Pubitemid 29131430)
8. G. Cui, X. Qin, Y. Zhang, Z. Gong, B. Ge, and Y.Q. Zang Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice J. Biol. Chem. 284 2009 28420 28429
9. G. Derosa, S.A. Salvadeo, A. D'Angelo, I. Ferrari, R. Mereu, I. Palumbo, P. Maffioli, S. Randazzo, and A.F. Cicero Metabolic effect of repaglinide or acarbose when added to a double oral anti-diabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial Curr. Med. Res. Opin. 25 2009 607 615
10. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.O. Quinkert, F. Martin, and C. Muller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
11. M.A. Hammad, and B.W. Muller Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles Eur. J. Pharm. Biopharm. 46 1998 361 367 (Pubitemid 29057685)
12. M. Imanshahidi, and H. Hosseinzadeh Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine Phytother. Res. 22 2008 999 1012
13. M.C. Jones, H. Gao, and J.C. Leroux Reverse polymeric micelles for pharmaceutical applications J. Controlled Release 132 2008 208 215
14. M.M. Kheir, Y. Wang, L. Hua, J. Hu, L. Li, F. Lei, and L. Du Acute toxicity of berberine and its correlation with the blood concentration in mice Food Chem. Toxicol. 48 2010 1105 1110
15. S.H. Kim, E.J. Shin, E.D. Kim, T. Bayaraa, S.C. Frost, and C.K. Hyun Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes Biol. Pharm. Bull. 30 2007 2120 2125 (Pubitemid 350097053)
16. C.J. Kirby Oil-based formulations for oral delivery of therapeutic peptides J. Liposome Res. 10 2000 391 407 (Pubitemid 32047464)
17. W.L. Li, H.C. Zheng, J. Bukuru, and N. De Kimpe Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus J. Ethnopharmacol. 92 2004 1 21 (Pubitemid 38510258)
18. L.Z. Liu, S.C. Cheung, L.L. Lan, S.K. Ho, H.X. Xu, J.C. Chan, and P.C. Tong Berberine modulates insulin signaling transduction in insulin-resistant cells Mol. Cell. Endocrinol. 317 2010 148 153
19. R.R.C. New, and C.J. Kirby Solubilisation of hydrophilic drugs in oily formulations Adv. Drug Deliv. Rev. 25 1997 59 69 (Pubitemid 27107791)
20. C.W. Pouton, and W.N. Charman The potential of oily formulations for drug delivery to the gastro-intestinal tract Adv. Drug Deliv. Rev. 25 1997 1 2 (Pubitemid 27107786)
21. L. Shargel, S. Wu-Pong, and A.B.C. Yu Pharmacokinetics of oral absorption L. Shargel, S. Wu-Pong, A.B.C. Yu, Applied Biopharmaceutics and Pharmacokinetics fifth ed. 2004 McGraw-Hill 714 Medical New York 161 184 (Chapter 7)
22. S. Sun Thousand Golden Prescriptions first ed. 2008 People's Publishing House of Inner Mongolia Hohhot
23. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16 (Pubitemid 44902565)
24. P.R. Vuddanda, S. Chakraborty, and S. Singh Berberine: a potential phytochemical with multispectrum therapeutic activities Expert Opin. Invest. Drugs 19 2010 1297 1307
25. P. Walde, A.M. Giuliani, C.A. Boicelli, and P.L. Luisi Phospholipid-based reverse micelles Chem. Phys. Lipids 53 1990 265 288 (Pubitemid 20101162)
26. T. Wang, Y. Deng, Y. Geng, Z. Gao, J. Zou, and Z. Wang Preparation of submicron unilamellar liposomes by freeze-drying double emulsions Biochim. Biophys. Acta 1758 2006 222 231 (Pubitemid 44294663)
27. N. Wang, T. Wang, T. Li, and Y. Deng Modulation of the physicochemical state of interior agents to prepare controlled release liposomes Colloids Surf. B Biointerfaces 69 2009 232 238
28. T. Wang, N. Wang, X. Jin, K. Zhang, and T. Li A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions J. Liposome Res. 19 2009 231 240
29. T. Wang, N. Wang, A. Hao, X. He, T. Li, and Y. Deng Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery Eur. J. Pharm. Sci. 39 2010 373 379
30. Y. Wang, T. Campbell, B. Perry, C. Beaurepaire, and L. Qin Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats Metabolism 60 2011 298 305
31. Wu, K.K., Huan, Y., 2008. Streptozotocin-induced Diabetic Models in Mice and Rats Current Protocols in Pharmacology, vol. 5. Wiley Interscience, San Francisco, CA, pp. 1-14.
32. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 57 2008 712 717 (Pubitemid 351608234)
33. J. Yin, H. Zhang, and J. Ye Traditional Chinese medicine in treatment of metabolic syndrome Endocr. Metab. Immune Disord. Drug Targets 8 2008 99 111
34. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42 (Pubitemid 32454482)
35. Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, and G. Ning Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine J. Clin. Endocrinol. Metab. 93 2008 2559 2565 (Pubitemid 352008520)
36. L. Zhou, Y. Yang, X. Wang, S. Liu, W. Shang, G. Yuan, F. Li, J. Tang, M. Chen, and J. Chen Berberine stimulates glucose transport through a mechanism distinct from insulin Metabolism 56 2007 405 412 (Pubitemid 46209231)
37. F. Zuo, N. Nakamura, T. Akao, and M. Hattori Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry Drug. Metab. Dispos. 34 2006 2064 2072 (Pubitemid 44837767)